Is functional iron deficiency the cause of anaemia in haemodialysis patients with dialysis catheters? A randomised controlled study

ISRCTN ISRCTN73108732
DOI https://doi.org/10.1186/ISRCTN73108732
Protocol serial number N0436121434
Sponsor Department of Health (UK)
Funder Leeds Teaching Hospitals NHS Trust (UK)
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
26/01/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Paul Laboi
Scientific

Department of Renal Medicine
Wellcome Wing
Leeds General Infirmary
Great George Street
Leeds
LS1 3EX
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleIs functional iron deficiency the cause of anaemia in haemodialysis patients with dialysis catheters? A randomised controlled study
Study objectivesTo confirm the presence of functional iron deficiency in iron replete haemodialysis patients with dialysis catheters.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHaemodialysis
InterventionRandomised controlled trial. Random allocation to:
1. Treatment one
2. Treatment two
Intervention typeOther
Primary outcome measure(s)

1. To determine the relationship between functional iron deficiency and EPO resistance.
2. Serum ferritin
3. iron
4. transferrin saturation
5. percentage of hypochromic erthrocytes
6. haematocrit
7. reticulocyte count
8. reticulocyte haemoglobin concentration
9. serum C-r

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/10/2003

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Key inclusion criteria1. Haemodialysis patients over 18 years of age on dialysis treatment for at least 3 months
2. Stable haemodialysis patients dialyzing with a central venous catheter on erythropoietin (EPO) therapy
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/10/2002
Date of final enrolment01/10/2003

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Leeds General Infirmary
Leeds
LS1 3EX
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

26/01/2016: no publications found on PubMed.